Related Experiment Video
Updated: Feb 19, 2026

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.3K
Gerstmann-Sträussler-Scheinker disease with atypical presentation.
Sarah E Keuss1, James W Ironside2, Jonathan O'Riordan1
1Department of Neurology, Ninewells Hospital, Dundee, Tayside, UK.
BMJ Case Reports
|November 3, 2017
Summary
A rare prion disease caused progressive neurological decline, including deafness, vision loss, and ataxia, in a 37-year-old woman. Genetic analysis revealed a mutation in the prion protein gene, confirmed postmortem.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Prion diseases are a group of fatal neurodegenerative disorders characterized by progressive neurological dysfunction.
- These diseases are caused by misfolded prion proteins that aggregate in the brain, leading to neuronal damage.
Observation:
- A 37-year-old woman presented with a decade-long history of progressive sensorineural hearing loss, visual impairment, and ataxia.
- Her condition advanced to include significant neuropsychiatric symptoms, such as cognitive decline, paranoid delusions, and fluctuating consciousness.
Findings:
- The patient was found to be heterozygous for the Q212P mutation in the prion protein gene (PRNP).
- Postmortem examination confirmed the diagnosis of a prion disease, likely a genetic form.
Implications:
- This case highlights the diverse clinical presentations of genetic prion diseases.
- Identifying specific mutations, like Q212P, aids in understanding disease mechanisms and potential diagnostic markers.
- Further research into PRNP mutations is crucial for developing targeted therapies for prionopathies.
Related Concept Videos
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
757
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
757
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K

